TransCode Therapeutics Inc. (RNAZ)
NASDAQ: RNAZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:42 AM ET
RNAZ stock chart
Technical analysisKey statistics
All statistics- Market cap
- $30.31M
- EPS (TTM)
- -$52.06
- Dividend yield
- None
- 52-week range
- 1.52 – 15.94
- Day range
- 1.68 – 1.80
- Volume / Avg
- 16.57K / 50.80K
- Beta
- —
- Shares outstanding
- 16.93M
52-week range
RNAZ stock today
On Oct 8, RNAZ is trading at $1.79, adding $0.03 (1.70%), versus the S&P 500's 0.35% decline. Shares are 88.8% below their 52-week high of $15.94 and 17.8% above the 52-week low of $1.52, near the bottom of the past year's range. RNAZ is down 74.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 85.6%.
TransCode Therapeutics has posted a net loss over the last twelve months (EPS of -$52.06), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About TransCode Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
TransCode Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NXTCNextCure Inc. | 6.51 | -0.76% | $29.80M | vs RNAZ |
| MIRAMIRA Pharmaceuticals Inc. | 0.6987 | -1.59% | $29.36M | vs RNAZ |
| GRDXGridAI Technologies Corp. | 4.38 | +6.31% | $31.23M | vs RNAZ |
| IGCIGC Pharma Inc. | 0.2806 | +0.21% | $29.01M | vs RNAZ |
| IMMPImmutep Limited ADR | 3.89 | -5.35% | $28.66M | vs RNAZ |
| CNTXContext Therapeutics Inc. | 0.3079 | -1.51% | $28.29M | vs RNAZ |
| RMTIRockwell Medical Inc. | 8.08 | -1.76% | $32.55M | vs RNAZ |
| ABVCABVC BioPharma Inc. | 0.9985 | -0.15% | $26.65M | vs RNAZ |
Indexes, lists and sector
TransCode Therapeutics stock FAQ
What is TransCode Therapeutics's stock price today?
RNAZ last traded at $1.79 as of Oct 8, 11:42 AM EDT, up 1.70% on the day. Prices are delayed at least 15 minutes.
Does TransCode Therapeutics pay a dividend?
No. TransCode Therapeutics does not currently pay a regular cash dividend.
Has RNAZ ever split its stock?
Yes. The most recent RNAZ stock split was a 1-for-28 split on May 15, 2025, one of 4 splits on record.
What is the RNAZ 52-week high?
The 52-week high for RNAZ is $15.94 and the 52-week low is $1.52. The stock is currently 88.8% below its high.